0001415889-23-012057.txt : 20230810 0001415889-23-012057.hdr.sgml : 20230810 20230810170959 ACCESSION NUMBER: 0001415889-23-012057 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230808 FILED AS OF DATE: 20230810 DATE AS OF CHANGE: 20230810 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAUKIEN FRANK H CENTRAL INDEX KEY: 0001133649 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30833 FILM NUMBER: 231160588 MAIL ADDRESS: STREET 1: C/O BRUKER DALTONICS STREET 2: 40 MANNING ROAD CITY: BILLERICA STATE: MA ZIP: 01821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRUKER CORP CENTRAL INDEX KEY: 0001109354 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 043110160 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 BUSINESS PHONE: 978663-3660 MAIL ADDRESS: STREET 1: 40 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 FORMER COMPANY: FORMER CONFORMED NAME: BRUKER BIOSCIENCES CORP DATE OF NAME CHANGE: 20030721 FORMER COMPANY: FORMER CONFORMED NAME: BRUKER DALTONICS INC DATE OF NAME CHANGE: 20000315 4 1 form4-08102023_090851.xml X0508 4 2023-08-08 0001109354 BRUKER CORP BRKR 0001133649 LAUKIEN FRANK H C/O BRUKER CORPORATION 40 MANNING ROAD BILLERICA MA 01821 true true true false PRESIDENT & CEO 0 Common Stock 2023-08-08 4 M 0 44150 47.85 A 38255291 D Common Stock 2023-08-08 4 S 0 37947 64.81 D 38217344 D Common Stock 1046499 I By Former Spouse Common Stock 337087 I By Son Common Stock 336607 I By Daughter Common Stock 201702 I As UTMA Custodian for Son Common Stock 71728 I As UTMA Custodian for Son Common Stock 492 I By Former Spouse Stock Option (Right to Purchase) 47.85 2023-08-08 4 M 0 44150 0 D 2023-08-06 2025-08-06 Common Stock 44150 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.44 to $65.71, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The stock option granted to the Reporting Person on August 6, 2020 (the "Original Grant Date") vested in equal installments on the first, second and third anniversaries of the Original Grant Date. /s/ Michael Simone 2023-08-10